"The Report EpiCast
Report: Hyperparathyroidism - Epidemiology Forecast to 2025 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
MarketResearchReports.biz has
announced the addition of a new market research report to its report
repository. The publication is titled, “EpiCast Report:
Hyperparathyroidism
- Epidemiology Forecast To 2025.” The study explores the growth
trajectory of the market over the last couple of years and the
prospects for growth in the coming years. The research publication
outlines the factors responsible for the variations in the market and
evaluates them meticulously. The effect of certain developments has
also been conversed in the research report. It also delivers data on
the market shares, marketing strategies, and products of leading
companies.
Hyperparathyroidism is a type
of disorder that happens in the parathyroid gland and occurs due to
the existence of unnecessary growth of the parathyroid hormone in the
bloodstream. A significant rise in the parathyroid glands activity
owing to inherent abnormal changes leads to variation in the
excretion of parathyroid hormone, and is thus known as Primary
Hyperparathyroidism or PHPT. Nevertheless, an extrinsic abnormal
changes impacting calcium homoeostasis, which triggers the production
of PTH and is thus called SHPT. In THPT, a situation of autonomous
excretion of PTH generally takes place due to longstanding CKD.
In order to project the
existing cases of PHPT that have been diagnosed, total current cases
of SHPT, and prevalent diagnosed cases of THPT, this epidemiology
study was conducted. It was projected in the report that the
prevalent diagnosed cases of Primary Hyperparathyroidism will
increase to 2,373,547 cases by 2025 from 2,055,167 in 2015 expanding
at an Annual Growth Rate of 1.55%. The U.S. is expected to have the
leading number of PHPT cases amongst the 7MM over the forecast
period. On the other hand, Japan is likely to account for
comparatively less number of PHPT cases. The report further predicts
that the total number prevalent SHPT cases will rise to 85,592,876
cases by the end of 2025 from 75,326,251 cases in 2015, rising at a
1.36% AGR.
The market for
hyperparathyroidism is expected to be driven by the growing
prevalence of chronic diseases of the kidney. Moreover, growing
number of products in the pipeline is expected to further drive the
growth of the market. However, there are certain side effects
associated with the treatment of hyperparathyroidism such as decline
in serum calcium, muscle spasm, and diarrhea. Low serum calcium level
also results in high heart failure risks die degraded myocardial
performance and hypotension. These factors are expected to hinder the
growth of the market in the coming years.
View Press Release @
http://www.marketresearchreports.biz/pressrelease/3741
The report talks about the
background of the disease, risk factors associated with it, trends,
number of cases prevalent in in HPT, SHPT, and THPT. It further
provides epidemiological forecast insight and an analysis of the
strengths and limitations.
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment